Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Diken

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Scientific Reports|April 23, 2014
Mutated tumor alleles are expressed according to their DNA frequencyJohn C Castle, Martin Loewer, Sebastian Boegel, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 11, 2017
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammationOlena Molokanova, Kai Schönig, Shih-Yen Weng, et al.
Nature Immunology|June 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent modelsNeha Agrawal, Louis S Ates, Stefan A Schille, et al.
Human Vaccines & Immunotherapeutics|July 18, 2015
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyLena M Kranz, Matthias Birtel, Christina Krienke, et al.
Biomaterials|March 2, 2015
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBiao Kang, Patricia Okwieka, Susanne Schöttler, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 13, 2016
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particlesNadine Leber, Leonard Kaps, Misbah Aslam, et al.
Plos Computational Biology|October 3, 2012
Confidence-based somatic mutation evaluation and prioritizationMartin Löwer, Bernhard Y Renard, Jos de Graaf, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Scientific Reports|April 23, 2014
Mutated tumor alleles are expressed according to their DNA frequencyJohn C Castle, Martin Loewer, Sebastian Boegel, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 11, 2017
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammationOlena Molokanova, Kai Schönig, Shih-Yen Weng, et al.
Nature Immunology|June 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent modelsNeha Agrawal, Louis S Ates, Stefan A Schille, et al.
Human Vaccines & Immunotherapeutics|July 18, 2015
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyLena M Kranz, Matthias Birtel, Christina Krienke, et al.
Biomaterials|March 2, 2015
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBiao Kang, Patricia Okwieka, Susanne Schöttler, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 13, 2016
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particlesNadine Leber, Leonard Kaps, Misbah Aslam, et al.
Plos Computational Biology|October 3, 2012
Confidence-based somatic mutation evaluation and prioritizationMartin Löwer, Bernhard Y Renard, Jos de Graaf, et al.
Pageof 10